Lipitor Diabetes Class Action Lawsuit-Like Centralized Management
A panel of federal judges has agreed to consolidate and centralize all Lipitor diabetes lawsuits filed in U.S. District Courts throughout the country. The litigation will be centralized before U.S. District Judge Richard M. Gergel in the District of South Carolina for coordinated management during pretrial proceedings and any early bellwether trials that may be scheduled.
Were You Diagnosed With Diabetes from Lipitor?
This process is often confused with a Lipitor class action lawsuit, but each case will remain an individual claim.
If a Lipitor settlement agreement or other resolution for the litigation is not reached following the MDL proceedings, each individual lawsuit may be remanded back to the U.S. District Court where it was originally filed in the future for a separate trial.
The diabetes lawyers at Saiontz & Kirk, P.A. represent women throughout the United States who are pursuing a case against Pfizer over their failure to adequately warn about the potential side effects of Lipitor.
Centralizing the federal litigation before one judge will benefit all plaintiffs involved in the cases, as it will reduce duplicative discovery and eliminate potentially conflicting rulings from different judges.
Lipitor MDL Centralized in South Carolina
The U.S. JPML previously rejected a similar request to centralize all of the Lipitor cases as part of an MDL, or Multidistrict Litigation. Following a hearing in July 2013, the panel found that there were an insufficient number of cases to justify the consolidated proceedings.
Over the past six months, the number of new cases has continued to increase at a rapid rate. There are currently several hundred cases pending in various different U.S. District Courts throughout the country, and many estimates indicate that there will soon be several thousand cases.
Following oral arguments on a renewed motion to establish a Lipitor MDL, the U.S. JPML ordered this week that all cases will be transferred to Judge Gergel in South Carolina.
This district was the first choice of most plaintiffs involved in the litigation, and Pfizer acknowledged that if an MDL was established this was an agreeable venue. Judge Gergel is already presiding over at least a dozen lawsuits involving Lipitor.
Lipitor Diabetes Lawyers
All of the Lipitor cases raise similar allegations that Pfizer aggressively promoted their blockbuster cholesterol drug without providing adequate information for consumers and the medical community about the risk of diabetes, especially among women.
While many otherwise healthy women began taking the cholesterol drug to reduce their risk of heart disease and promote their healthy life-style, they have now been left with the devastating complications associated with diabetes from Lipitor.
The Lipitor lawyers at Saiontz & Kirk, P.A. provide free consultations and claim evaluations for women throughout the United States who have been diagnosed with diabetes after taking Lipitor.
All Liptior lawsuits are handled on a contingency fee basis, which means that there are never any out-of-pocket expenses to hire our law firm and we receive no attorney fees or expenses unless a recovery is obtained.